awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36245541-E8DE1221-A407-43A0-AAAD-F31E722CBF61
Q36245541-E8DE1221-A407-43A0-AAAD-F31E722CBF61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245541-E8DE1221-A407-43A0-AAAD-F31E722CBF61
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
P2860
Q36245541-E8DE1221-A407-43A0-AAAD-F31E722CBF61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245541-E8DE1221-A407-43A0-AAAD-F31E722CBF61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a82581ec8bff1316869b3ca7d0193dcfeabcb80
P2860
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).